Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name YH001
Trade Name
Synonyms YH 001|YH-001
Drug Descriptions

YH001 is a humanized anti-CTLA4 antibody that may block immunosuppression in tumor microenvironment and enhance antitumor immune response (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2577-2577).

DrugClasses CTLA4 Antibody 29
CAS Registry Number NA
NCIT ID C176873

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Doxorubicin + Envafolimab + YH001 Doxorubicin Envafolimab YH001 0 1
Envafolimab + YH001 Envafolimab YH001 0 1
Pembrolizumab + YH001 + YH003 Pembrolizumab YH001 YH003 0 1
Toripalimab-tpzi + YH001 Toripalimab-tpzi YH001 0 2
YH001 YH001 0 0
YH001 + YH002 YH001 YH002 0 1


Additional content available in CKB BOOST